Axonics Modulation Technologies (AXNX) Competitor Comparison
We are evaluating the key criteria listed to compare Axonics Modulation Technologies (AXNX) against its competitors in the Medical Devices industry.
Market Capitalization
18 / 92Gross Profits
32 / 85Total Revenue
32 / 89EBITDA
35 / 90Free Cashflow
51 / 90Quick Ratio
6 / 90Earnings per Share
34 / 90Dividend yield
0 / 8Total Cash
17 / 90Performance 3 years
15 / 92Performance 5 years
8 / 92Performance 10 years
12 / 92Linearity 3 years
10 / 92Linearity 5 years
83 / 92Linearity 10 years
80 / 92Total Rank
50 / 92Dividend Rank
79 / 92Valuation Rank
24 / 92Piotroski Rank
9 / 92Muliplier Rank
77 / 92Total Cash - AXNX ranking 17 / 90
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.